Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Juan José Gorgojo-Martínez, Samuel J. P. Malkin, Virginia Martín, Nino Hallén & Barnaby Hunt. (2020) Assessing the cost-effectiveness of a once-weekly GLP-1 analogue versus an SGLT-2 inhibitor in the Spanish setting: Once-weekly semaglutide versus empagliflozin. Journal of Medical Economics 23:2, pages 193-203.
Read now
Read now
Articles from other publishers (21)
Johan Jendle, Maria Ida BuompensiereAsli Zeynep Ozdemir SaltikSimona de PortuJayne Smith-Palmer, Richard F. PollockOhad Cohen. (2023) A European Cost–Utility Analysis of the MiniMed™ 780G Advanced Hybrid Closed-Loop System Versus Intermittently Scanned Continuous Glucose Monitoring with Multiple Daily Insulin Injections in People Living with Type 1 Diabetes. Diabetes Technology & Therapeutics 25:12, pages 864-876.
Crossref
Crossref
Domingo Orozco-Beltrán, Adriana López Pineda, José Antonio Quesada, Esther Artime, Silvia Díaz-Cerezo, Jennifer Redondo-Antón, Miriam Rubio-de Santos, Erik Spaepen & María Concepción Carratala Munuera. (2023) Barriers and solutions for the management of severe hypoglycaemia in people with diabetes in Spain: A Delphi survey. Primary Care Diabetes.
Crossref
Crossref
Ana Rita Soares, Marisa Coelho, Marsha Tracey, Davide Carvalho & José Silva-Nunes. (2023) Epidemiological, Social and Economic Burden of Severe Hypoglycaemia in Patients with Diabetes Mellitus in Portugal: A Structured Literature Review. Diabetes Therapy 14:2, pages 265-291.
Crossref
Crossref
Isabel Leiva-Gea, Rocío Porcel Chacón, Ana Belén Ariza Jiménez, María Mora Loro, Leopoldo Tapia-Ceballos, Jose Jiménez-Hinojosa, Ana Gómez Perea & Juan Pedro López Siguero. (2022) Impacto en hipoglucemia grave y costes sanitarios del uso del sistema FreeStyle en población pediátrica con diabetes mellitus tipo 1. Endocrinología, Diabetes y Nutrición 69:8, pages 561-565.
Crossref
Crossref
Isabel Leiva-Gea, Rocío Porcel Chacón, Ana Belén Ariza Jiménez, María Mora Loro, Leopoldo Tapia-Ceballos, Jose Jiménez-Hinojosa, Ana Gómez Perea & Juan Pedro López Siguero. (2022) Impact on variables of severe hypoglycaemia and healthcare costs of the use of the FreeStyle system in paediatric population with type 1 diabetes mellitus. Endocrinología, Diabetes y Nutrición (English ed.) 69:8, pages 561-565.
Crossref
Crossref
Vaia LambadiariAsli Zeynep Ozdemir SaltikSimona de PortuMaria Ida BuompensiereAikaterini KountouriEmmanouil KorakasHelen Sharland & Ohad Cohen. (2022) Cost-Effectiveness Analysis of an Advanced Hybrid Closed-Loop Insulin Delivery System in People with Type 1 Diabetes in Greece. Diabetes Technology & Therapeutics 24:5, pages 316-323.
Crossref
Crossref
Beatrice Osumili, Esther Artime, Beth Mitchell, Miriam Rubio-de Santos, Silvia Díaz-Cerezo, Marga Giménez, Erik Spaepen, Helen Sharland & William J. Valentine. (2022) Cost of Severe Hypoglycemia and Budget Impact with Nasal Glucagon in Patients with Diabetes in Spain. Diabetes Therapy 13:4, pages 775-794.
Crossref
Crossref
Elisabeth Mönnig, Erik Spaepen, Beatrice Osumili, Beth D. Mitchell, Frank Snoek, Mark Peyrot, Werner Kern & Andreas Holstein. (2020) Conversations and Reactions Around Severe Hypoglycaemia (CRASH): Results from the German Cohort of a Global Survey of People with Type 1 Diabetes or Insulin-Treated Type 2 Diabetes and Caregivers. Experimental and Clinical Endocrinology & Diabetes 130:03, pages 145-155.
Crossref
Crossref
F. Javier Ampudia-Blasco, Esther Artime, Silvia Díaz, Miriam Rubio, Jesús Reviriego, Beth Mitchell, Beatrice Osumili, Mark Peyrot, Robin Pokrzywinski, Erik Spaepen & Frank Snoek. (2021) Conversations and Reactions Around Severe Hypoglycaemia (CRASH): Spanish results of a global survey of people with type 1 diabetes or insulin-treated type 2 diabetes and caregivers. Endocrinología, Diabetes y Nutrición 68:8, pages 557-566.
Crossref
Crossref
F. Javier Ampudia-Blasco, Esther Artime, Silvia Díaz, Miriam Rubio, Jesús Reviriego, Beth Mitchell, Beatrice Osumili, Mark Peyrot, Robin Pokrzywinski, Erik Spaepen & Frank Snoek. (2021) Conversations and Reactions Around Severe Hypoglycaemia (CRASH): Spanish results of a global survey of people with type 1 diabetes or insulin-treated type 2 diabetes and caregivers. Endocrinología, Diabetes y Nutrición (English ed.) 68:8, pages 557-566.
Crossref
Crossref
Lizheng Shi, Vivian Fonseca & Belinda Childs. (2021) Economic burden of diabetes-related hypoglycemia on patients, payors, and employers. Journal of Diabetes and its Complications 35:6, pages 107916.
Crossref
Crossref
Claude Le Pen, Bernard Bauduceau, Xavier Ansolabehere, Arnaud Troubat, Sébastien Bineau, Mahaut Ripert & Sylvie Dejager. (2021) Penetration rates of new pharmaceutical products in Europe: A comparative study of several classes recently launched in type-2 diabetes. Annales d'Endocrinologie 82:2, pages 99-106.
Crossref
Crossref
Gyorgy Jermendy, Agnes Kecskes & Attila Nagy. (2021) Nocturnal Hypoglycaemia in Patients with Diabetes Mellitus: Database Analysis of a Cohort Using Telemedicine Support for Self-Monitoring of Blood Glucose over a 10-Year-Long Period. Medicina 57:2, pages 167.
Crossref
Crossref
Virginia Martín, Josep Vidal, Samuel J. P. Malkin, Nino Hallén & Barnaby Hunt. (2020) Evaluation of the Long-Term Cost-Effectiveness of Once-Weekly Semaglutide Versus Dulaglutide and Sitagliptin in the Spanish Setting. Advances in Therapy 37:10, pages 4427-4445.
Crossref
Crossref
Gebrewahd Bezabh Gebremichael & Teklewoini Mariye Zemicheal. (2020) Hypoglycemia Prevention Practice and Associated Factors among Diabetic Patients on Follow-Up at Public Hospitals of Central Zone, Tigray, Ethiopia, 2018. International Journal of Endocrinology 2020, pages 1-7.
Crossref
Crossref
Valentin Brodszky, Zsuzsanna Beretzky, Petra Baji, Fanni Rencz, Márta Péntek, Alexandru Rotar, Konstantin Tachkov, Susanne Mayer, Judit Simon, Maciej Niewada, Rok Hren & László Gulácsi. (2019) Cost-of-illness studies in nine Central and Eastern European countries. The European Journal of Health Economics 20:S1, pages 155-172.
Crossref
Crossref
Mercedes Núñez, Silvia Díaz, Tatiana Dilla, Jesús Reviriego & Antonio Pérez. (2019) Epidemiology, Quality of Life, and Costs Associated with Hypoglycemia in Patients with Diabetes in Spain: A Systematic Literature Review. Diabetes Therapy 10:2, pages 375-392.
Crossref
Crossref
Richard Hellmund, Raimund Weitgasser & Deirdre Blissett. (2018) Cost calculation for a flash glucose monitoring system for UK adults with type 1 diabetes mellitus receiving intensive insulin treatment. Diabetes Research and Clinical Practice 138, pages 193-200.
Crossref
Crossref
Martin Haluzik, Adam Kretowski, Krzysztof Strojek, Leszek Czupryniak, Andrej Janez, Peter Kempler, Michal Andel, Tsvetalina Tankova, Mihail Boyanov, Lea Smircic Duvnjak, Laszlo Madacsy, Iwona Tarnowska, Marcin Zychma & Nebojsa Lalic. (2018) Perspectives of Patients with Insulin-Treated Type 1 and Type 2 Diabetes on Hypoglycemia: Results of the HAT Observational Study in Central and Eastern European Countries. Diabetes Therapy 9:2, pages 727-741.
Crossref
Crossref
B. Detournay, S. Halimi, E. Torreton & P. Levy. (2017) Coût des hospitalisations pour hypoglycémie en France chez les patients diabétiques de type 2 : étude fondée sur le PMSI et la base EGB de la CNAMTS. Médecine des Maladies Métaboliques 11, pages IIS16-IIS19.
Crossref
Crossref
Witesh Parekh, Nicki Hoskins, James Baker-Knight, Antonio Ramirez de Arellano & Pedro Mezquita Raya. (2017) The Economic Burden of Insulin-Related Hypoglycemia in Spain. Diabetes Therapy 8:4, pages 899-913.
Crossref
Crossref